We revisit some of our favorite recent interviews including Bloomberg’s Eric Balchunas, Vanguard’s Rich Powers, iShares’ Martin Small, and Charles Schwab’s David Botset.
Podcast: Play in new window | Download
With hard data easily accessible to every investor, the active versus passive management debate has, in many ways, been put to rest. Nate & Conor revisit some of the most recent data in an attempt to see if anything has changed. Christian Magoon, CEO of Amplify ETFs, spotlights the Amplify YieldShares CWP Dividend & Option Income ETF (DIVO).
Podcast: Play in new window | Download
Investing in precious metals has never been easier with the growth of ETFs. Nate & Conor discuss the basics of owning precious metals in a portfolio and explain why precious metal ETFs are a compelling option. Maxwell Gold, Director of Investment Strategy at ETF Securities, surveys the current precious metals landscape and offers his perspective on why owning precious metals can make sense.
Podcast: Play in new window | Download
Two proposed ETFs, the Winklevoss Bitcoin Trust and the Emerging AgroSphere ETF, are currently in registration with the Securities & Exchange Commission. Nate and Jason explain the backstories behind these ETFs and offer some perspective on their potential investment merit. Maz Jadallah, CEO & Founder of AlphaClone, spotlights the AlphaClone International ETF and discusses the concept of “active indexing”.
Podcast: Play in new window | Download
Biotech industry expert Brad Loncar discusses his approach to investing in biotech stocks and key current drivers in the sector. Brad also offers his perspective on broad-based biotech ETFs and explains the index behind the Loncar Cancer Immunotherapy ETF (CNCR). Nate & Jason spotlight the First Trust NYSE Arca Biotechnology Index Fund (FBT).
Podcast: Play in new window | Download
